TRANSLATIONAL STEM CELL THERAPY FOUNDATION INC

EIN: 274358901 501(c)(3)

GILBERT, AZ

Total Revenue
$512,000
Total Expenses
$222,300
Total Assets
$512,606
Net Assets
$512,606
🔒

Financial Vulnerability Assessment (Tuckman-Chang)

4 risk indicators measuring financial stability and operational resilience

Sign in with your work email to view Tuckman-Chang indicators

Sign In — Free (10 views/day)

Financial Trends

Organization Details

Formation Year
2010
Legal Domicile
AZ
Tax Period
2021-01-01 to 2021-12-31

TRANSLATIONAL STEM CELL THERAPY FOUNDATION INC, founded in 2010, is a small nonprofit that reported $512K in total revenue in fiscal year 2021. The organization ran a surplus of $290K, a strong 57% operating margin.

Mission

The Foundation will operate as a public charity to raise awareness of the medical benefits of stem cell research, foster increased donations by the public of cord blood and perform research on cord blood stem cells.

🔒

Trantor Score

Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency

Sign in to view Trantor Score and financial metrics

Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)

Sign In — Free (10 views/day)

Financial Overview (2021)

Revenue Breakdown

Contributions & Grants $512,000
Program Service Revenue $0
Investment Income $0
Other Revenue $0
TOTAL REVENUE $512,000

Expense Breakdown

Grants Paid $0
Salaries & Benefits $67,008
Fundraising Expenses $0
Program Expenses $217,201
Other Expenses $155,292
TOTAL EXPENSES $222,300

Year-over-Year Comparison

2021 2020 Change
Revenue $512,000 $495,632 +0.0%
Expenses $222,300 $394,448 -0.4%
Net Income $289,700 $101,184 +1.9%
Key Indicators
✗ Grants to Organizations ✗ Grants to Individuals ✗ Lobbying ✗ Political Activity ✗ Foreign Activities ✗ Donor Advised Fund ✗ Schedule B Required
🔒

Financial Health Indicators

Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics

Financial Distress Indicator

Liquidity & Cash Position

Sign in to view all financial metrics

Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics

Sign In

Governance

Voting Members
2
Independent Members
N/A
Employees
1
Volunteers
N/A

Governance Policies

✗ Conflict of Interest Policy
✗ Whistleblower Policy
✗ Document Retention Policy

Special Practices & Reported Activities

✗ Operated a School
✗ Operated a Hospital
✗ Provided First Class Travel
✗ Reported Conflict of Interest
✗ Reported Asset Diversion
✗ Excess Benefit Transaction
✗ Made Political Expenditures
✗ Engaged in Lobbying
✗ Operated Donor Advised Fund
✗ Maintained Art Collections
✗ Filed Form 720

Compensation of Officers, Directors & Key Employees

Total Officers
2
$62,400
Total Directors
2
$62,400
Key Employees
0
$0
Highest Compensated
0
reported
Name Title Hours/Week Role Reportable Comp Other Comp Total
LORRI LAWSON Director/Presid 40.00
Officer Director
$62,400 $0 $62,400
LOUIS SARATOGA Secretary 2.00
Officer Director
$0 $0 $0
Note: Compensation data is self-reported by the organization on their Form 990. "Reportable Comp" includes salary, bonuses, and other reportable compensation from the organization and related organizations. "Other Comp" includes benefits, deferred compensation, and non-taxable benefits.

Historical Data

Year Revenue Expenses Assets Net Income
2021 $512,000 $222,300 $512,606 $289,700
2020 $495,632 $394,448 $237,516 $101,184
2019 $399,252 $579,301 $123,332 $-180,049
2018 $326,209 $157,197 $303,342 $169,012
Explore More Nonprofits
→Top 100 Nonprofits in Arizona →Largest U.S. Nonprofits →Best Rated Nonprofits →Most Efficient Nonprofits

Compare TRANSLATIONAL STEM CELL THERAPY FOUNDATION INC with other nonprofits in Arizona and across the country.

We Value Your Privacy
We use cookies and similar technologies to analyze site traffic and improve your experience. By clicking "Accept All", you consent to our use of cookies for analytics and measurement.